Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?

Annals of Surgical Oncology

Volumn 18, Issue 9, 2011, Pages 2654-2661

  Ramos, Emilio ^a   Valls, Carlos ^a   Martinez, Laura ^a   Lladó, Laura ^a   Torras, Jaume ^a   Ruiz, Sandra ^a   Gamez, Cristina ^b   Serrano, Teresa ^a   Fabregat, Joan ^a   Rafecas, Antonio ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b PET Unit of the Instituto de Dianostico por la Imagen (ID)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED CONTRAST MEDIUM;

ADULT; ALLERGY; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COLORECTAL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FATTY LIVER; FEMALE; HUMAN; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY;

COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052769823     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1670-y     Document Type: Article

References (38)

1. C Valls E Andía A Sanchez A Guma J Figueras J Torras T Serrano, et al. 2001 Helical CT in liver metastases from colorectal cancer: preoperative detection and assessment of resectability Radiology. 218 55 60 11152779 1:STN:280:DC%2BD3MzitFCltg%3D%3D (Pubitemid 32151272)
2. J Schmidt M Strotzer S Fraunhofer H Boedeker H Zirngibl 2000 Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis World J Surg. 24 1 43 47 10594202 10.1007/ s002689910009 1:STN:280:DC%2BD3c%2Fmtlersg%3D%3D
3. J Ward F Chen JA Guthrie D Wilson JP Lodge JI Wyatt PJ Robinson 1999 Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis Radiology. 210 2 459 466 10207430 1:STN:280:DyaK1M3itlygtQ%3D%3D (Pubitemid 29055316)
4. SM Strasberg F Dehdashti BA Siegel JA Drebin D Linehan 2001 Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study Ann Surg. 233 3 293 299 11224615 10.1097/00000658-200103000-00001 1:STN:280:DC%2BD3M7ps1emtQ%3D%3D (Pubitemid 32187806)
5. DL Joyce RL Wahl PV Patel RD Schulick SL Gearhart MA Choti 2006 Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases Arch Surg. 141 12 1220 1226 17178965 10.1001/archsurg.141.12.1220 discussion 7 (Pubitemid 44956639)
6. T Arulampalam D Costa D Visvikis P Boulos I Taylor P Ell 2001 The impact of FDG-PET on the management algorithm for recurrent colorectal cancer Eur J Nucl Med. 28 12 1758 1765 11734912 10.1007/s002590100646 1:CAS:528: DC%2BD3MXosFagurg%3D
7. FG Fernandez JA Drebin DC Linehan, et al. 2004 Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET) Ann Surg. 240 3 438 447 15319715 10.1097/01.sla.0000138076.72547.b1 discussion 47-50 (Pubitemid 39121338)
8. S Adie C Yip F Chu DL Morris 2009 Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning? ANZ J Surg. 79 5 358 361 19566517 10.1111/j.1445-2197. 2009.04889.x
9. SC Chua AM Groves I Kayani, et al. 2007 The impact of 18F-FDG PET/CT in patients with liver metastases Eur J Nucl Med Mol Imaging. 34 12 1906 1914 17713766 10.1007/s00259-007-0518-y (Pubitemid 350212127)
10. Z Kula J Szefer Z Zuchora G Romanowicz T Pietrzak 2004 Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer Pol Merkur Lekarski. 17 Suppl 1 63 66 15603351 (Pubitemid 39237345)
11. N Lubezky U Metser R Geva, et al. 2007 The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings J Gastrointest Surg. 11 4 472 478 17436132 10.1007/s11605-006-0032-8
12. S Truant D Huglo M Hebbar O Ernst M Steinling FR Pruvot 2005 Prospective evaluation of the impact of [18F]fluoro-2-deoxy-d-glucose positron emission tomography of resectable colorectal liver metastases Br J Surg. 92 3 362 369 15672427 10.1002/bjs.4843 1:STN:280:DC%2BD2M7hslyiuw%3D%3D (Pubitemid 40445601)
13. M Selzner TF Hany P Wildbrett L McCormack Z Kadry PA Clavien 2004 Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg. 240 6 1027 1034 15570208 10.1097/01.sla.0000146145.69835.c5 discussion 35-6 (Pubitemid 39602130)
14. E Ramos L Martinez C Gamez, et al. 2008 Use of PET-CT in pre-surgical staging of colorectal cancer hepatic metastases Cir Esp. 84 2 71 77 18682184 10.1016/S0009-739X(08)72137-7
15. S Badiee BL Franc EM Webb B Chu RA Hawkins F Coakley 2008 Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases AJR Am J Roentgenol. 191 5 1436 1439 18941082 10.2214/AJR.07.3750
16. K Coenegrachts F De Geeter L Beek N Walgraeve S Bipat J Stoker H Rigauts 2009 Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases Eur Radiol. 19 2 370 379 18795299 10.1007/s00330-008-1163-y
17. MM D'Souza R Sharma A Mondal, et al. 2009 Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases Nucl Med Commun. 30 2 117 125 19057427 10.1097/MNM.0b013e32831ec57b
18. H Kuehl G Antoch H Stergar, et al. 2008 Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results Eur J Radiol. 67 2 362 371 18155866 10.1016/j.ejrad.2007.11.017
19. A Orlacchio O Schillaci N Fusco, et al. 2009 Role of PET/CT in the detection of liver metastases from colorectal cancer Radiol Med. 114 4 571 585 19444590 10.1007/s11547-009-0393-7 1:STN:280:DC%2BD1MrmsVOgtA%3D%3D
20. JD Soyka P Veit-Haibach K Strobel, et al. 2008 Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice? J Nucl Med. 49 3 354 361 18287263 10.2967/jnumed.107.048249 (Pubitemid 351355199)
21. J Votrubova O Belohlavek M Jaruskova, et al. 2006 The role of FDG-PET/CT in the detection of recurrent colorectal cancer Eur J Nucl Med Mol Imaging. 33 7 779 784 16565845 10.1007/s00259-006-0072-z (Pubitemid 43979685)
22. B Wiering WV Vogel TJ Ruers WJG Oyen 2008 Controversies in the management of colorectal liver metastases: role of PET and PET/CT Dig Surg. 25 6 413 420 19212113 10.1159/000184732
23. S Khan YM Tan A John J Isaac S Singhvi P Guest DF Mirza 2006 An audit of fusion CT-PET in the management of colorectal liver metastases Eur J Surg Oncol. 32 5 564 567 16564155 10.1016/j.ejso.2006.02.003 1:STN:280: DC%2BD28zgt12hug%3D%3D (Pubitemid 44226008)
24. TJ Ruers BS Langenhoff N Neeleman, et al. 2002 Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study J Clin Oncol. 20 2 388 395 11786565 10.1200/JCO.20.2.388 1:STN:280:DC%2BD38%2FmtV2jtg%3D%3D (Pubitemid 34072520)
25. RH Huebner KC Park JE Shepherd J Schwimmer J Czernin ME Phelps SS Gambhir 2000 A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer J Nucl Med. 41 7 1177 1189 10914907 1:STN:280:DC%2BD3czpslemtw%3D%3D (Pubitemid 30464000)
26. B Wiering PF Krabbe GJ Jager WJ Oyen TJ Ruers 2005 The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases Cancer. 104 12 2658 2670 16315241 10.1002/cncr.21569 (Pubitemid 41798276)
27. TJ Ruers B Wiering JR van der Sijp, et al. 2007 Improved selection of patients for hepatic surgery of colorectal liver metastases with 18F-FDG PET: a randomized study J Nucl Med. 12 1036 1041
28. CM Schüssler-Fiorenza DM Mahvi J Niederhuber LF Rikkers SM Weber 2004 Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases J Gastrointest Surg. 8 2 150 157 15036190 10.1016/j.gassur.2003.11.009 discussion 7-8 (Pubitemid 38224256)
29. G Kong C Jackson DM Koh, et al. 2008 The use of 18F-FDG PET/CT in colorectal liver metastases-comparison with CT and liver MRI Eur J Nucl Med Mol Imaging. 35 7 1323 1329 18347794 10.1007/s00259-008-0743-z 1:STN:280: DC%2BD1cznvFOqsg%3D%3D
30. G Grassetto A Fornasiero G Bonciarelli, et al. 2010 Additional value of FDG-PET/CT in management of "solitary" liver metastases: preliminary results of a prospective multicenter study Mol Imaging Biol. 12 2 139 144 19626378 10.1007/s11307-009-0249-5
31. K Kinkel Y Lu M Both RS Warren RF Thoeni 2002 Detection of hepatic metastases from cancer of the gastrointestinal tract by using non invasive imaging methods (US, CT, MR imaging, PET): a meta-analysis Radiology. 224 748 756 12202709 10.1148/radiol.2243011362 (Pubitemid 34919808)
32. S Bipat MS van Leeuwen EFI Comans, et al. 2005 Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis Radiology. 237 123 131 16100087 10.1148/radiol.2371042060 (Pubitemid 41346155)
33. ED Rappeport A Loft AK Berthelsen, et al. 2007 Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation Acta Radiol. 48 4 369 378 17453514 10.1080/02841850701294560 1:STN:280:DC%2BD2szlt1Grug%3D%3D (Pubitemid 46633866)
34. T Akhurst TJ Kates M Mazumdar, et al. 2005 Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases J Clin Oncol. 23 34 8713 8716 16314631 10.1200/JCO.2005.04.4222 (Pubitemid 46211515)
35. PP Mainenti M Mancini C Mainolfi, et al. 2010 Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents Abdom Imaging. 35 5 511 521 19562412 10.1007/s00261-009-9555-2
36. B Taouli DM Koh 2010 Diffusion-weighted MR imaging of the liver Radiology. 254 47 66 20032142 10.1148/radiol.09090021
37. B Wiering PF Krabbe HM Dekker WJG Oyen TJM Ruers 2007 The role of FDG-PET in the selection of patients with colorectal liver metastases Ann Surg Oncol. 14 2 771 779 17086488 10.1245/s10434-006-9013-0 1:STN:280: DC%2BD2s%2Fks1SgsQ%3D%3D (Pubitemid 46175326)
38. B Wiering TJ Ruers PF Krabbe HM Dekker WJG Oyen 2007 Comparison of multiphase CT, FDG-PET and intraoperative ultrasound in patients with colorectal liver metastases selected for surgery Ann Surg Oncol. 14 2 818 826 17136470 10.1245/s10434-006-9259-6 1:STN:280:DC%2BD2s%2Fks1Wlsw%3D%3D (Pubitemid 46175332)